Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for RedHill Biopharma (RDHL) over the last 10 years, with Q2 2025 value amounting to $1.0 million.

  • RedHill Biopharma's Prepaid Assets fell 6528.02% to $1.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.0 million, marking a year-over-year decrease of 6528.02%. This contributed to the annual value of $1.1 million for FY2024, which is 6058.55% down from last year.
  • Latest data reveals that RedHill Biopharma reported Prepaid Assets of $1.0 million as of Q2 2025, which was down 6528.02% from $1.1 million recorded in Q4 2024.
  • RedHill Biopharma's 5-year Prepaid Assets high stood at $5.2 million for Q1 2023, and its period low was $1.0 million during Q2 2025.
  • Its 5-year average for Prepaid Assets is $3.4 million, with a median of $3.4 million in 2022.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 15523.69% in 2021, then plummeted by 6528.02% in 2025.
  • Quarter analysis of 5 years shows RedHill Biopharma's Prepaid Assets stood at $4.7 million in 2021, then decreased by 5.88% to $4.4 million in 2022, then tumbled by 36.15% to $2.8 million in 2023, then tumbled by 60.59% to $1.1 million in 2024, then fell by 8.51% to $1.0 million in 2025.
  • Its Prepaid Assets stands at $1.0 million for Q2 2025, versus $1.1 million for Q4 2024 and $2.9 million for Q2 2024.